Compare SSII & BOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SSII | BOT |
|---|---|---|
| Founded | N/A | N/A |
| Country | India | Puerto Rico |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 750.5M | 767.9M |
| IPO Year | 2017 | 2025 |
| Metric | SSII | BOT |
|---|---|---|
| Price | $3.42 | $26.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 38.3K | ★ 425.8K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,484,747.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 105.74 | N/A |
| 52 Week Low | $3.11 | $23.60 |
| 52 Week High | $10.00 | $43.72 |
| Indicator | SSII | BOT |
|---|---|---|
| Relative Strength Index (RSI) | 38.06 | 45.31 |
| Support Level | $3.25 | $25.03 |
| Resistance Level | $4.16 | $31.14 |
| Average True Range (ATR) | 0.21 | 2.41 |
| MACD | -0.03 | -0.22 |
| Stochastic Oscillator | 20.00 | 12.66 |
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
RoboStrategy Inc is a closed-end, non-diversified management investment company. The Fund's investment objective is to seek long-term capital appreciation, principally through capital gains on equity and equity-linked investments in robotics and embodied AI companies. The Fund focuses on private, venture-capital-backed companies with growth potential, many of which are not yet publicly listed or widely accessible to individual investors.